Arch Biopartners Inc. (ACHFF)
OTCMKTS · Delayed Price · Currency is USD
0.3161
0.00 (0.00%)
At close: May 26, 2026
Arch Biopartners Market Cap
Arch Biopartners has a market cap or net worth of $21.47 million as of May 27, 2026. Its market cap has decreased by -73.36% in one year.
Market Cap
21.47M
Enterprise Value
23.39M
Revenue
115.29K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.32
Market Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has decreased from 33.63M to 21.47M, a decrease of -36.14%. That is a compound annual growth rate of -2.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 21.47M | -63.68% |
| Dec 31, 2025 | 59.13M | -32.56% |
| Dec 31, 2024 | 87.67M | 25.12% |
| Dec 29, 2023 | 70.07M | -46.02% |
| Dec 30, 2022 | 129.79M | -23.83% |
| Dec 31, 2021 | 170.40M | 138.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 27.32M |
| Oncotelic Therapeutics | 25.74M |
| Anebulo Pharmaceuticals | 18.76M |
| ZIVO Bioscience | 16.42M |
| Galera Therapeutics | 16.06M |
| Zeo ScientifiX | 15.40M |
| EOM Pharmaceuticals Holdings | 14.55M |
| HOOKIPA Pharma | 14.47M |